Literature DB >> 15539883

Relaxation induced by acetylcholine involves endothelium-derived hyperpolarizing factor in 2-kidney 1-clip hypertensive rat carotid arteries.

Ana Paula Sendão Oliveira1, Lusiane M Bendhack.   

Abstract

Acetylcholine induced relaxation in a concentration-dependent way in isolated phenylephrine-contracted carotid artery rings from normotensive two-kidney (2K) and hypertensive two-kidney one-clip (2K-1C) rats. In the presence of the nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine (L-NOARG, 100 micromol/l), the relaxation stimulated with acetylcholine was blocked in 2K arteries. However, in 2K-1C arteries, the relaxation was only partially inhibited. Indomethacin (3 micromol/l) had no effect in both groups. In 2K arteries, the combination of L-NOARG and indomethacin had similar effects to L-NOARG alone. On the other hand, in 2K-1C arteries, indomethacin further inhibited the maximum effect induced by acetylcholine. Endothelium-dependent relaxation induced by acetylcholine was markedly reduced in 2K arteries contracted with 90 mmol/l KCl, and it was abolished in 2K-1C arteries. The remaining response to acetylcholine in 2K arteries was blocked by L-NOARG. Thus, in addition to NO, a relaxing factor sensitive to extracellular K+ changes in the membrane potential contributes to endothelium-dependent relaxation in 2K-1C rat carotid artery. On the other hand, in arteries from 2K rats, only NO is involved in the relaxation induced by acetylcholine. The combination of 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ, 3 micromol/l), indomethacin (3 micromol/l) and L-NOARG (100 micromol/l) reduced the relaxation induced by acetylcholine in arteries from 2K-1C rats contracted with phenylephrine. On the other hand, in 2K arteries, the relaxation induced by acetylcholine was abolished. The combination of ODQ and K+ channel blockers charybdotoxin (100 nmol/l), apamin (500 nmol/l) and 4-aminopyridine (1 micromol/l) abolished the relaxation induced by acetylcholine in 2K and 2K-1C carotid arteries. These data indicate that the endothelium-derived relaxing factors that contribute to relaxation induced by acetylcholine are different in 2K and 2K-1C arteries. In 2K arteries, the only factor is NO, which involves the activation of K+ channels and the cGMP pathway. However, in 2K-1C arteries, the relaxation induced by acetylcholine is dependent on NO in addition to another factor, which is insensitive to indomethacin, but also activates the K+ channels and the cGMP pathway, presumably by membrane hyperpolarization through endothelium-derived hyperpolarizing factor. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539883     DOI: 10.1159/000080378

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Erectile function in two-kidney, one-clip hypertensive rats is maintained by a potential increase in nitric oxide production.

Authors:  A Elizabeth Linder; Anne M Dorrance; Thomas M Mills; R Clinton Webb; Romulo Leite
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

2.  In vitro Treatment with cis-[Ru(H-dcbpy-)2(Cl)(NO)] Improves the Endothelial Function in Aortic Rings with Endothelial Dysfunction.

Authors:  Jorge Camargo Oishi; Tereza Cristina Buzinnari; Cezar Rangel Pestana; Thiago Francisco De Moraes; Izabela Pereira Vatanabe; David Anderson Wink; Roberto Santana da Silva; Lusiane Maria Bendhack; Gerson Jhonatan Rodrigues
Journal:  J Pharm Pharm Sci       Date:  2015       Impact factor: 2.327

Review 3.  Endothelium-Dependent Hyperpolarization (EDH) in Hypertension: The Role of Endothelial Ion Channels.

Authors:  Kenichi Goto; Toshio Ohtsubo; Takanari Kitazono
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

4.  Mechanisms of phytoestrogen biochanin A-induced vasorelaxation in renovascular hypertensive rats.

Authors:  Seok Choi; Won Suk Jung; Nam Soo Cho; Kwon Ho Ryu; Jae Yeoul Jun; Byung Chul Shin; Jong Hoon Chung; Cheol Ho Yeum
Journal:  Kidney Res Clin Pract       Date:  2014-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.